CLINICAL_TRIALS
trial_result
· 2024-04-11
Clinical Trial Update: Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome [Phase 3]
Summary
Open-label extension study results for trofinetide in Rett syndrome completed with results posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ACADIA Pharmaceuticals Inc. | Conditions: Rett Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2024-04-11